DIFFICULTY IN ACHIEVING THERAPEUTIC SERUM CONCENTRATIONS OF SALICYLATE IN KAWASAKI DISEASE

被引:29
作者
KOREN, G
MACLEOD, SM
机构
关键词
D O I
10.1016/S0022-3476(84)80097-9
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
引用
收藏
页码:991 / 995
页数:5
相关论文
共 13 条
[1]   KAWASAKI SYNDROME IN THE UNITED-STATES - 1976 TO 1980 [J].
BELL, DM ;
MORENS, DM ;
HOLMAN, RC ;
HURWITZ, ES ;
HUNTER, MK .
AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1983, 137 (03) :211-214
[2]  
Gibaldi M., 1982, PHARMACOKINETICS, P145
[3]  
GOODMAN LS, 1980, PHARMACOL BASIS THER, P688
[4]   SALICYLATE TREATMENT OF EPIDEMIC KAWASAKI DISEASE IN NEW-YORK-CITY [J].
JACOBS, JC .
THERAPEUTIC DRUG MONITORING, 1979, 1 (01) :123-130
[5]  
KATO H, 1979, PEDIATRICS, V63, P175
[6]  
KAWASAKI T, 1967, JAP J ALLERG, V16, P178, DOI DOI 10.4070/KCJ.2018.0214
[7]  
MAKELA AL, 1975, SCAND J RHEUMATOL, V4, P250
[8]  
MELISH ME, 1982, HOSP PRACT, V17, P99
[9]   INHIBITION OF PROSTACYCLIN AND PLATELET THROMBOXANE A2 AFTER LOW-DOSE ASPIRIN [J].
PRESTON, FE ;
WHIPPS, S ;
JACKSON, CA ;
FRENCH, AJ ;
WYLD, PJ ;
STODDARD, CJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1981, 304 (02) :76-79
[10]  
RUSSELL AS, 1975, CAN MED ASSOC J, V112, P1210